Selective immune adsorption treatment of severe guillain barré syndrome in the intensive care unit

Neurocritical Care

Volumn 11, Issue 3, 2009, Pages 317-321

  Galldiks, N ^a   Dohmen, C ^a   Neveling, M ^a   Fink, G R ^a   Haupt, W F ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Acute inflammatory demyelinating polyradiculoneuropathy (AIDP); Hughes grade; Intravenous immunoglobulin (IVIG); Selective immune adsorption (SIA) in combination with IVIG GBS

Indexed keywords

FIBRINOGEN; IMMUNOGLOBULIN;

ADULT; AGED; ARTICLE; AUTONOMIC DYSFUNCTION; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FIBRINOGEN BLOOD LEVEL; FIBRINOGEN DEFECT; FOLLOW UP; GUILLAIN BARRE SYNDROME; HEART ARRHYTHMIA; HUMAN; HYPOTENSION; IMMUNOADSORPTION; INTENSIVE CARE UNIT; INTERMETHOD COMPARISON; MALE; PLASMAPHERESIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM; SELECTIVE IMMUNE ADSORPTION; SYMPTOM; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT WITHDRAWAL;

ADULT; AGED; COMBINED MODALITY THERAPY; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSORBENT TECHNIQUES; IMMUNOTHERAPY; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 71949097411     PISSN: 15416933     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12028-009-9252-6     Document Type: Article

References (17)

1. AF Hahn 1998 Guillain-Barre syndrome Lancet 352 635 641 10.1016/S0140-6736(97)12308-X 1:STN:280:DyaK1cvhslWhsA%3D%3D 9746040 (Pubitemid 28380155)
2. K Arasaki S Kusunoki N Kudo I Kanazawa 1993 Acute conduction block in vitro following exposure to antiganglioside sera Muscle Nerve 16 587 593 10.1002/mus.880160603 1:STN:280:DyaK3s3nsFemtQ%3D%3D 8502255 (Pubitemid 23157329)
3. Efficiency of plasma exchange in Guillain-Barre syndrome: role of replacement fluids. French Cooperative Group on Plasma Exchange in Guillain-Barre syndrome. Ann Neurol. 1987;22:753-61.
4. Plasmapheresis and acute Guillain-Barre syndrome. The Guillain-Barre syndrome Study Group. Neurology. 1985;35:1096-104.
5. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barre syndrome. Plasma Exchange/Sandoglobulin Guillain-Barre Syndrome Trial Group. Lancet. 1997;349:225-30.
6. WF Haupt F Rosenow C van der Ven H Borberg G Pawlik 1996 Sequential treatment of Guillain-Barre syndrome with extracorporeal elimination and intravenous immunoglobulin J Neurol Sci 137 145 149 10.1016/0022-510X(95)00357-8 1:STN:280:DyaK28znsFyrsg%3D%3D 8782169
7. HC Diener WF Haupt TM Kloss, et al. 2001 A preliminary, randomized, multicenter study comparing intravenous immunoglobulin, plasma exchange, and immune adsorption in Guillain-Barre syndrome Eur Neurol 46 107 109 10.1159/000050777 1:STN:280:DC%2BD3MvosFKluw%3D%3D 11528165 (Pubitemid 32786141)
8. S Okamiya M Ogino Y Ogino, et al. 2004 Tryptophan-immobilized column-based immunoadsorption as the choice method for plasmapheresis in Guillain-Barre syndrome Ther Apher Dial 8 248 253 10.1111/j.1526-0968.2004. 00138.x 1:CAS:528:DC%2BD2cXmtlSlurY%3D 15154879 (Pubitemid 38900432)
9. T Seta H Nagayama K Katsura, et al. 2005 Factors influencing outcome in Guillain-Barre syndrome: comparison of plasma adsorption against other treatments Clin Neurol Neurosurg 107 491 496 10.1016/j.clineuro.2004.12.019 16202823 (Pubitemid 41395225)
10. A Pencz E Garnier 1990 Immunoadsorption in the treatment of Guillain-Barre type polyradiculitis Nervenarzt 61 372 375 1:STN:280: DyaK3czjt1SqsQ%3D%3D 2198477
11. C Jimenez F Rosenow P Grieb WF Haupt H Borberg 1993 Adsorption therapy with tryptophan-conjugated polyvinyl alcohol gels in 10 patients with acute Guillain-Barre syndrome Transfus Sci 14 9 11 10.1016/0955-3886(93)90046-W 1:STN:280:DyaK3sbgtlahug%3D%3D 10148309 (Pubitemid 23058352)
12. N Shibuya T Sato M Osame T Takegami S Doi S Kawanami 1994 Immunoadsorption therapy for myasthenia gravis J Neurol Neurosurg Psychiatry 57 578 581 10.1136/jnnp.57.5.578 1:STN:280:DyaK2c3mtVaisg%3D%3D 8201327
13. D Grob D Simpson H Mitsumoto, et al. 1995 Treatment of myasthenia gravis by immunoadsorption of plasma Neurology 45 338 344 1:STN:280: DyaK2M7lslOmtA%3D%3D 7854536
14. RA Hughes JM Newsom-Davis GD Perkin JM Pierce 1978 Controlled trial prednisolone in acute polyneuropathy Lancet 2 750 753 10.1016/S0140-6736(78) 92644-2 1:STN:280:DyaE1M%2FgvFKjtg%3D%3D 80682
15. FG van der Meche PI Schmitz 1992 A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barre syndrome. Dutch Guillain-Barre Study Group N Engl J Med 326 1123 1129 1552913
16. AK Asbury DR Cornblath 1990 Assessment of current diagnostic criteria for Guillain-Barre syndrome Ann Neurol 27 Suppl S21 S24 10.1002/ana.410270707 2194422 (Pubitemid 20178648)
17. RA Hughes EF Wijdicks R Barohn, et al. 2003 Practice parameter: immunotherapy for Guillain-Barre syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology 61 736 740 1:STN:280:DC%2BD3svksVKhsw%3D%3D 14504313